Drugs.com - FDA MedWatch Alerts

FDA Investigating Serious Risk of Hematologic Malignancy Following Skysona (elivaldogene autotemcel)

Audience: Health Professional November 27, 2024 -- Since approval, the Food and Drug Administration (FDA) has received additional reports of hematologic malignancies, including life-threatening cases of myelodysplastic syndrome and acute myeloid...

Feb 9, 2025 - 21:44
 0
FDA Investigating Serious Risk of Hematologic Malignancy Following Skysona (elivaldogene autotemcel)
Audience: Health Professional November 27, 2024 -- Since approval, the Food and Drug Administration (FDA) has received additional reports of hematologic malignancies, including life-threatening cases of myelodysplastic syndrome and acute myeloid...
Read More

Tags:

Previous Article

Buy-herbal.com Issues Voluntary Nationwide Recall of Nhan Sam Tuyet Lien Truy Ph...

Next Article

Mxbbb Issues Voluntary Nationwide Recall of Umary Acid Hyaluronic Due to the Pre...

Related Posts

Dr. Reddy’s Issues a Nationwide Recall of Levetiracetam in 0.75% Sodium Chloride Injection 1,000 mg/100 mL, in the U.S., Due to Mislabeling of Infusion Bag

Dr. Reddy’s Issues a Nationwide Recall of Levetiracetam...

Mar 14, 2025  0

FDA Warns Consumers Not to Use Counterfeit Ozempic (semaglutide) Found in U.S. Drug Supply Chain

FDA Warns Consumers Not to Use Counterfeit Ozempic (sem...

Apr 15, 2025  0

Drug Safety Communication: FDA Adds Warning About Rare Occurrence of Serious Liver Injury with Use of Veozah (fezolinetant) for Hot Flashes Due to Menopause

Drug Safety Communication: FDA Adds Warning About Rare ...

Feb 9, 2025  0